Results
|
581.
|
Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients. [electronic resource] by
- Ocaña, Alberto
- Rodríguez-Barbero, Alicia
- Pericacho, Miguel
- Bellido, Lorena
- Seijas, Raquel
- López, Rafael
- Delgado, Carlota
- de Prado, Diego Soto
- Cruz-Hernández, Juan J
- López-Novoa, José M
Producer: 20071015
In:
Cancer letters vol. 255
Availability: No items available.
|
|
582.
|
|
|
583.
|
|
|
584.
|
|
|
585.
|
|
|
586.
|
|
|
587.
|
|
|
588.
|
|
|
589.
|
(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy. [electronic resource] by
- Karmani, Linda
- Bouchat, Virginie
- Bouzin, Caroline
- Levêque, Philippe
- Labar, Daniel
- Bol, Anne
- Deumer, Gladys
- Marega, Riccardo
- Bonifazi, Davide
- Haufroid, Vincent
- Michiels, Carine
- Grégoire, Vincent
- Feron, Olivier
- Lucas, Stéphane
- Vander Borght, Thierry
- Gallez, Bernard
Producer: 20150629
In:
Nanomedicine (London, England) vol. 9
Availability: No items available.
|
|
590.
|
|
|
591.
|
|
|
592.
|
|
|
593.
|
|
|
594.
|
|
|
595.
|
|
|
596.
|
|
|
597.
|
|
|
598.
|
|
|
599.
|
|
|
600.
|
|